Matches in SemOpenAlex for { <https://semopenalex.org/work/W2133010487> ?p ?o ?g. }
- W2133010487 endingPage "2829" @default.
- W2133010487 startingPage "2811" @default.
- W2133010487 abstract "Gemcitabine is one of the most widely used pyrimidine analogues, with a well-established role as a first- and second-line treatment of several types of tumors. Several preclinical and clinical studies have been done to obtain information on molecular determinants of gemcitabine activity and metabolism, in order to predict whether this drug will be effective and safe for the individual patient. Among these molecular determinants, the mRNA and protein expression of equilibrative transporter-1 (ENT1) and ribonucleotide reductase (RR) emerged as possible predictors of drug activity in studies on pancreatic and non-small cell lung cancer. However, cytidine deaminase polymorphisms and activity were correlated with clinical outcome and severe toxicities, whereas further studies should evaluate both P53 dependent and independent pathways involved in gemcitabine induced apoptosis. Improved knowledge on these determinants is critical for the optimal development of combination of gemcitabine with other conventional or biological therapies, as well as to exploit the radiosensitizing potential of gemcitabine. Emerging technologies such as massive parallel sequencing, gene expression arrays and proteomics may identify novel biomarkers in tumor material, while polymorphisms and phenotyping analysis should unravel factors involved in drug toxicity. Validation of these markers in preclinical models should be used for the appropriate patient enrolment into subsequent prospective studies. Hopefully, novel pharmacogenetic biomarkers will be validated in these prospective studies and used to select cancer patients to be treated with gemcitabine-based regimens in the near future or to enroll them in studies with prodrugs in order to bypass resistance mechanisms. Keywords: Gemcitabine, pharmacogenetics, equilibrative transporter-1, cytidine deaminase, drug combination, radiosensitization, polymorphisms, ribonucleotide reductase (RR), biomarkers, prodrugs" @default.
- W2133010487 created "2016-06-24" @default.
- W2133010487 creator A5035296183 @default.
- W2133010487 creator A5041229832 @default.
- W2133010487 creator A5042640895 @default.
- W2133010487 date "2012-05-01" @default.
- W2133010487 modified "2023-10-16" @default.
- W2133010487 title "Molecular Targets of Gemcitabine Action: Rationale for Development of Novel Drugs and Drug Combinations" @default.
- W2133010487 cites W113740469 @default.
- W2133010487 cites W1513812979 @default.
- W2133010487 cites W1520702439 @default.
- W2133010487 cites W1527154821 @default.
- W2133010487 cites W1527742565 @default.
- W2133010487 cites W1626199312 @default.
- W2133010487 cites W1680634601 @default.
- W2133010487 cites W1735395619 @default.
- W2133010487 cites W1795204252 @default.
- W2133010487 cites W1848316250 @default.
- W2133010487 cites W1857358013 @default.
- W2133010487 cites W1898871412 @default.
- W2133010487 cites W1905254767 @default.
- W2133010487 cites W1908696053 @default.
- W2133010487 cites W1930516194 @default.
- W2133010487 cites W1963767651 @default.
- W2133010487 cites W1968323734 @default.
- W2133010487 cites W1970280907 @default.
- W2133010487 cites W1971904680 @default.
- W2133010487 cites W1971928019 @default.
- W2133010487 cites W1972185917 @default.
- W2133010487 cites W1972245712 @default.
- W2133010487 cites W1972318387 @default.
- W2133010487 cites W1972666371 @default.
- W2133010487 cites W1973378645 @default.
- W2133010487 cites W1974091141 @default.
- W2133010487 cites W1975377779 @default.
- W2133010487 cites W1975462581 @default.
- W2133010487 cites W1977607540 @default.
- W2133010487 cites W1977726277 @default.
- W2133010487 cites W1978427676 @default.
- W2133010487 cites W1979439649 @default.
- W2133010487 cites W1979572755 @default.
- W2133010487 cites W1979840126 @default.
- W2133010487 cites W1980023082 @default.
- W2133010487 cites W1981172071 @default.
- W2133010487 cites W1981360370 @default.
- W2133010487 cites W1982630848 @default.
- W2133010487 cites W1983466982 @default.
- W2133010487 cites W1985268469 @default.
- W2133010487 cites W1985309622 @default.
- W2133010487 cites W1988508837 @default.
- W2133010487 cites W1990615874 @default.
- W2133010487 cites W1991116833 @default.
- W2133010487 cites W1991264254 @default.
- W2133010487 cites W1992045535 @default.
- W2133010487 cites W1992769392 @default.
- W2133010487 cites W1992859406 @default.
- W2133010487 cites W1992881313 @default.
- W2133010487 cites W1994411692 @default.
- W2133010487 cites W1995076802 @default.
- W2133010487 cites W1995226018 @default.
- W2133010487 cites W1997005484 @default.
- W2133010487 cites W1997104648 @default.
- W2133010487 cites W1997599629 @default.
- W2133010487 cites W1997782851 @default.
- W2133010487 cites W1998267367 @default.
- W2133010487 cites W1999537037 @default.
- W2133010487 cites W1999653639 @default.
- W2133010487 cites W2000932071 @default.
- W2133010487 cites W2003813442 @default.
- W2133010487 cites W2004869577 @default.
- W2133010487 cites W2005128402 @default.
- W2133010487 cites W2005144917 @default.
- W2133010487 cites W2006115835 @default.
- W2133010487 cites W2008842695 @default.
- W2133010487 cites W2009632514 @default.
- W2133010487 cites W2010281770 @default.
- W2133010487 cites W2010458879 @default.
- W2133010487 cites W2012432138 @default.
- W2133010487 cites W2014417524 @default.
- W2133010487 cites W2014742104 @default.
- W2133010487 cites W2014900505 @default.
- W2133010487 cites W2017471791 @default.
- W2133010487 cites W2022030994 @default.
- W2133010487 cites W2024934599 @default.
- W2133010487 cites W2025917207 @default.
- W2133010487 cites W2028331391 @default.
- W2133010487 cites W2033009598 @default.
- W2133010487 cites W2035105453 @default.
- W2133010487 cites W2035728564 @default.
- W2133010487 cites W2036224413 @default.
- W2133010487 cites W2036364900 @default.
- W2133010487 cites W2038362000 @default.
- W2133010487 cites W2038921550 @default.
- W2133010487 cites W2041477067 @default.
- W2133010487 cites W2043173598 @default.
- W2133010487 cites W2047171262 @default.
- W2133010487 cites W2049894527 @default.
- W2133010487 cites W2050115564 @default.